FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $2.5B
1-Year Est. Return 52.94%
This Quarter Est. Return
1 Year Est. Return
+52.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.67B
AUM Growth
+$293M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
53
New
Increased
Reduced
Closed

Top Buys

1
+$29.1M
2
+$24.4M
3
+$18.2M
4
ORIC icon
Oric Pharmaceuticals
ORIC
+$16.6M
5
BBIO icon
BridgeBio Pharma
BBIO
+$14.1M

Top Sells

1
+$11.6M
2
+$11.6M
3
+$7.79M
4
RNA icon
Avidity Biosciences
RNA
+$7.67M
5
REPL icon
Replimune Group
REPL
+$6.97M

Sector Composition

1 Healthcare 99.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$168M 10.04%
9,781,472
2
$167M 9.97%
4,345,559
3
$145M 8.65%
10,109,279
+1,702,127
4
$129M 7.72%
10,871,803
+1,530,252
5
$116M 6.94%
990,260
+44,853
6
$113M 6.74%
4,360,107
+500,000
7
$82.8M 4.94%
8,684,232
8
$77.6M 4.64%
3,708,838
9
$62.2M 3.72%
2,944,349
10
$58.2M 3.47%
1,164,405
-233,000
11
$35.7M 2.13%
2,167,222
+2,483
12
$34.2M 2.04%
1,988,876
+817,226
13
$32.3M 1.93%
1,787,527
14
$30.7M 1.83%
2,985,757
15
$29.1M 1.74%
3,238,859
16
$29.1M 1.74%
+655,000
17
$25.5M 1.52%
1,414,823
18
$22.9M 1.37%
854,484
19
$21M 1.25%
2,248,194
20
$20.5M 1.23%
857,338
21
$19.7M 1.17%
746,479
22
$18.3M 1.09%
899,700
23
$17.8M 1.06%
1,501,383
-657,771
24
$17.5M 1.05%
1,028,013
-393,297
25
$17.1M 1.02%
28,425
+18,765
1
2 3